ELYRIA, Ohio–(BUSINESS WIRE)–Invacare (NYSE:IVC) (“Invacare” or the “Company”) announces that it will release its financial results for the first quarter 2013 before the market opens on Thursday, April 25, 2013. At that time, the Company also plans to give an update on its certification audits relating to the consent decree with the United States Food and Drug Administration (FDA) at its Taylor Street wheelchair manufacturing and corporate facilities in Elyria, Ohio.
The Company will sponsor a conference call for investors and other interested parties on Thursday, April 25 at 8:30 AM EDT to discuss the Company’s performance. Those wishing to participate in the live call should dial 1-888-498-8379, or 1-706-679-5239 for international callers, and enter meeting ID 34526733.
A digital recording will be available two hours after completion of the conference call from April 25, 2013 through May 2, 2013. To access the recording, US/Canada callers should dial 1-855-859-2056 or 1-404-537-3406 for international callers, and enter the Conference ID 34526733.
Invacare (NYSE:IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The Company has approximately 6,000 associates and markets its products in 80 countries around the world. For more information about the Company and its products, visit Invacare’s website at www.invacare.com.
Contact:
Invacare
Investor Inquiries:
Lara Mahoney, 440-329-6393